Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy

European Journal of Human Genetics

Volumn 11, Issue 9, 2003, Pages 659-664

  Poirier, Odette ^a   Nicaud, Viviane ^a   McDonagh, Theresa ^b   Dargie, Henry J ^b   Desnos, Michel ^c   Dorent, Richard ^a   Roizès, Gérard ^d   Schwartz, Ketty ^e   Tiret, Laurence ^a   Komajda, Michel ^a   Cambien, François ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Hopital Boucicaut   (France)

^d INSTITUTE OF HUMAN GENETICS   (France)

^e INSERM   (France)

Author keywords

Association study; Calcineurin; Cardiac hypertrophy; Genetic polymorphisms

Indexed keywords

ALANINE; CALCINEURIN; GLYCINE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENZYME ACTIVE SITE; FEMALE; GENE ACTIVATION; GENE FREQUENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SCREENING; HEART DILATATION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; STRUCTURE ANALYSIS;

CALCINEURIN; CARDIOMEGALY; DNA-BINDING PROTEINS; ECHOCARDIOGRAPHY; GATA4 TRANSCRIPTION FACTOR; GENETIC SCREENING; HUMANS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TRANSCRIPTION FACTORS;

EID: 12444276290     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201023     Document Type: Article

References (13)

1. Molkentin JD, Dorn G: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63: 391-426.
2. Balke CW, Shorofsky SR: Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998; 37: 290-299.
3. Wang MG, Yi H, Guerini D, Klee CB, McBride OW: Calcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21→q22 and 2p16→p15 respectively. Cytogenet Cell Genet 1996; 72: 236-241.
4. Molkentin JD, Lu JR, Antos CL et al: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
5. McDonagh TA, Morrison CE, Lawrence A et al: Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-833.
6. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
7. Tiret L, Mallet C, Poirier O et al: Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
8. Tiret L, Amouyel P, Rakotovao R, Cambien F, Ducimetiere P: Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet 1991; 48: 926-934.
9. Schneider S, Roessli D, Excoffier L: Arlequin: a software for population genetics data analysis. Ver 2.000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva, 2000.
10. Poirier O, Nicaud V, Vionnet N et al: Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients. Diabetes 2001; SO: 1214-1218.
11. Horsley V, Pavlath GK: NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 2002; 156: 771-774.
12. Crabtree GR: Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 1999; 96: 611-614.
13. Henikoff S, Henikoff JG: Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992; 89: 10915-10919.